Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time
10. Mai 2021 13:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
NASDAQ: FLDM Investor Notice: Lawsuit against Fluidigm Corporation announced by Shareholders Foundation
08. Dezember 2020 07:15 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in NASDAQ: FLDM shares. Investors, who purchased shares...
FLDM STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Fluidigm Corporation – FLDM
06. Oktober 2020 12:35 ET
|
Zhang Investor Law P.C.
NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Fluidigm Corporation (NASDAQ: FLDM) between February 7,...
Fluidigm Achieves Initial Milestone under NIH Rapid Acceleration of Diagnostics Agreement
08. September 2020 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm and SIgN Establish the First Center of Excellence in Singapore to Advance Imaging Mass Cytometry
11. März 2020 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
03. März 2020 08:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
Fluidigm Completes Acquisition of InstruNor AS
26. Februar 2020 08:30 ET
|
Fluidigm Corporation
Acquisition to expand Fluidigm’s industry-leading mass cytometry capabilities and address flow cytometry markets with the addition of fully automated sample prep SOUTH SAN FRANCISCO, Calif., Feb. ...
Fluidigm Establishes Center of Excellence at NCI-Designated Comprehensive Cancer Center to Advance Imaging Mass Cytometry
10. Februar 2020 16:02 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm CyTOF Technology Selected by Covance to Develop Highly Multiplexed Human Immune Profiling Services
10. Februar 2020 08:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life...
Landmark Nature Publication Demonstrates the Power of the Fluidigm Hyperion Imaging System to Identify Novel Cellular Signatures That Correlate with Distinct Clinical Outcomes
20. Januar 2020 11:32 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced that a new landmark...